Výsledky vyhledávání - "Vincent Ducros"

TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma

Autor: Jérôme Solassol, Géraldine Chauchard, Vincent Ducros, Pauline Blateau, Estelle M.N. Laurent, Benoît Béganton, Etienne Coyaud, Julie A. Vendrell

Publikováno v: Cancers, Vol 12, Iss 2224, p 2224 (2020)
Cancers
Cancers, 2020, 12 (8), pp.2224. ⟨10.3390/cancers12082224⟩
Cancers, MDPI, 2020, 12 (8), pp.2224. ⟨10.3390/cancers12082224⟩
Volume 12
Issue 8

Although the development of mitogen-activated protein kinase (MAPK) inhibitors has greatly improved the prognosis of BRAFV600 cutaneous melanomas, the identification of molecular indicators for mutated patients at risk of early progression remains a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85e5d962992b865ffc352cbd7d465048
https://www.mdpi.com/2072-6694/12/8/2224

Zobrazit plný text záznamu

Alu element insertion in the MLH1 exon 6 coding sequence as a mutation predisposing to Lynch syndrome

Autor: Carole Corsini, Pascal Pujol, Jean Chiesa, Jérôme Solassol, Jean-Marc Rey, Vincent Ducros, Julie Leclerc, Marion Larrieux

Publikováno v: Human Mutation
Human Mutation, Wiley, 2019, 40 (6), pp.716-720. ⟨10.1002/humu.23725⟩

International audience; Lynch syndrome (LS) is the most frequent cause of hereditary colorectal cancer. A subset of patients with a history of LS shows no causal germline pathogenic alteration and are identified as having Lynch‐like syndrome (LLS).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83e6489c3c4b1b944a38e8057bdfda64
https://pubmed.ncbi.nlm.nih.gov/30815977

Zobrazit plný text záznamu

Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing

Autor: Thierry Maudelonde, Pascal Pujol, Hanaa Aissaoui, Jean-Marc Rey, Vincent Ducros, Qing Wang, Marie-Pierre Buisine, Sylviane Olschwang

Publikováno v: Journal of Molecular Diagnostics
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2017, 19 (4), pp.589-601. ⟨10.1016/j.jmoldx.2017.04.005⟩
Journal of Molecular Diagnostics, 2017, 19 (4), pp.589-601. ⟨10.1016/j.jmoldx.2017.04.005⟩

International audience; Identification of genetic alterations is important for family risk assessment in colorectal cancers. Next-generation sequencing (NGS) technologies provide useful tools for single-nucleotide and copy number variation (CNV) iden

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d95833a249151890728207bf908114e
https://pubmed.ncbi.nlm.nih.gov/28502729

Zobrazit plný text záznamu

MarketLine Company Profile: Getlink SE.

Publikováno v: Getlink SE MarketLine Company Profile. 7/25/2023, p1-26. 26p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

MarketLine Company Profile: Getlink SE.

Publikováno v: Getlink SE MarketLine Company Profile. 9/1/2021, p1-25. 25p.

Zobrazit plný text záznamu

MarketLine Company Profile: Getlink SE.

Publikováno v: Getlink SE MarketLine Company Profile. 10/5/2020, p1-25. 25p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma.

Autor: Blateau, Pauline^1,2 (AUTHOR) p-blateau@chu-montpellier.fr, Coyaud, Etienne³ (AUTHOR) coyaud@gmail.com, Laurent, Estelle³ (AUTHOR) estellelaurent81@gmail.com, Béganton, Benoit^1,2 (AUTHOR) b-beganton@chu-montpellier.fr, Ducros, Vincent¹ (AUTHOR) v-ducros@chu-montpellier.fr, Chauchard, Géraldine¹ (AUTHOR) g-chauchard@chu-montpellier.fr, Vendrell, Julie A.¹ (AUTHOR) j-vendrell@chu-montpellier.fr, Solassol, Jérôme^1,2 (AUTHOR) j-solassol@chu-montpellier.fr

Publikováno v: Cancers. Aug2020, Vol. 12 Issue 8, p2224-2224. 1p.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání